Categories  |  Inventors

Technology Overview

OHSU # 1744-A — Anti-CB1 / Anti-CNR1 monoclonal antibodies: (clone 3A3 - conformationally sensitive)

Technology Overview

The mouse monoclonal antisera against human Cannabinoid Receptor 1 (anti-CB1, anti-CNR1). Clone: 3A3. The laboratory of Dr. David Farren’s has produced the only monoclonal antibodies on the market that recognizes the well conserved 3rd intracellular loop of CB1 (connecting transmembrane domains 5 and 6). Antiserum from clone 3A3 can recognize native, solubilized CB1 receptor in fluorescence detected size-exclusion chromatography.

Antibody: anti-CB1

Hybridoma cell line: Clone 3A3
Isotype: Mouse IgG2b, kappa
Species reactivity: Human (may cross react with mouse and rat)
Concentration: 1.0 mg/mL

Applications: Western blot (1:50,000); Immunofluorescence (1:1,000)
Availability:  The antisera, purified antibodies, and hybridoma clone are available for non-exclusive licensing.


Related Technologies

  • OHSU # 1744-C — Anti-CB1 / Anti-CNR1 Monoclonal Antibodies: (Clone 6E2)
  • OHSU # 1744-B — Anti-CB1 / Anti-CNR1 Monoclonal Antibodies: (Clone 5G3)


Agreement Type Price
NE Biological Materials License $500.00